Ivabradine to prevent anthracycline-induced cardiotoxicity: an ongoing prospective randomized, open-label clinical trial
Angiotensin II Receptor Blocker vs. Calcium Channel Blocker in the Treatment of Bevacizumab induced Hypertension: Comparison of Serum VEGF level